A RESEARCH STUDY EVALUATING PROTEINURIA I.E. PROTEINS IN THE URINE REDUCING EFFICACY OF ANGIOTENSIN RECEPTOR BLOCKERS LOSARTAN, TELMISARTAN AND OLMESARTA
Phase 4
Completed
- Conditions
- Health Condition 1: null- Proteinuria, Kidney disease
- Registration Number
- CTRI/2011/05/001765
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
Patients of either gender above 18yrs of age
Willing to give written informed consent
Proteinuria more than 1000mg/day confirmed on two consecutive 24 hr urine samples and with serum creatinine less than 2 mg/dl
Exclusion Criteria
Pregnancy or planned childbearing during specified study period
Serum creatinine more than 2 mg/dl and/or potassium more than 4.8mg/dl
Preexisting severe hepatic dysfunction
Uncontrolled hypertension (>160/100 mmHg)
Uncontrolled diabetes (random blood sugar >300)
Hemodynamic instability (systolic BP <90mmHg, NYHA III-IV CCF or other condition as judged by physician)
Bilateral renal artery stenosis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method